Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt repayments

Hims & Hers Health (HIMS) Shares Issued (2019 - 2026)

Hims & Hers Health's Shares Issued history spans 7 years, with the latest figure at $5.0 million for Q1 2026.

On a quarterly basis, Shares Issued rose 27.49% to $5.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 million, a 95.77% decrease, with the full-year FY2024 number at $26.7 million, changed N/A from a year prior.
Shares Issued hit $5.0 million in Q1 2026 for Hims & Hers Health, up from -$9.8 million in the prior quarter.
Over the last five years, Shares Issued for HIMS hit a ceiling of $25.0 million in Q4 2024 and a floor of -$14.8 million in Q3 2024.
Historically, Shares Issued has averaged $1.9 million across 5 years, with a median of $579000.0 in 2022.
The widest YoY moves for Shares Issued: up 3519.68% in 2024, down 4493.49% in 2024.
Tracing HIMS's Shares Issued over 5 years: stood at -$2.2 million in 2022, then soared by 58.37% to -$898000.0 in 2023, then surged by 2887.19% to $25.0 million in 2024, then plummeted by 139.14% to -$9.8 million in 2025, then soared by 151.12% to $5.0 million in 2026.
Business Quant data shows Shares Issued for HIMS at $5.0 million in Q1 2026, -$9.8 million in Q4 2025, and $6.8 million in Q3 2025.